<!DOCTYPE html>
<html lang="en">
  <head>
    <!-- Required meta tags -->
    <meta charset="utf-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1" />

    <title>Efficacy Data</title>

    <link rel="stylesheet" href="assets/css/bootstrap.min.css" />
    <link rel="stylesheet" href="assets/css/all.min.css" />
    <link rel="stylesheet" href="assets/css/owl.carousel.min.css" />
    <link rel="stylesheet" href="assets/css/style.css" />
  </head>
  <body class="vertical-bg efficacy-vertical-bg">
    
    <!-- start header section -->
    <header id="header-section">
      <div class="header-top">
        <div
          class="
            container
            d-sm-flex
            flex-wrap flex-md-nowrap
            text-center
            justify-content-center justify-content-md-between
            align-items-center
          "
        >
          <p class="tg-regular mb-0 mt-1 mt-sm-0 me-auto">
            For Canadian residents only
          </p>
          <a href="safty-profile.html" class="c-darkblue tg-bold-20"
            >Safety Information & References</a
          >
          <a href="safty-profile.html" class="c-darkblue tg-bold-20"
            >Product Monograph</a
          >
          <a href="#" class="mb-1 mb-sm-0">
            <img src="assets/images/top-logo.png" alt="" />
          </a>
        </div>
      </div>
      <div class="header-main tg-bold-20">
        <div
          class="
            container
            d-flex
            flex-wrap
            align-items-center
            justify-content-between
          "
        >
          <a href="/" class="logo">
            <img src="assets/images/logo.png" alt="" />
          </a>
          <i class="fas fa-bars d-lg-none"></i>
          <nav class="text-uppercase d-lg-flex align-items-center">
            <ul class="d-lg-flex">
              <li><a href="home.html">Home</a></li>
              <li><a href="study-design.html">Study Designs</a></li>
              <li><a class="active" href="efficacy-1.html">Efficacy Data</a></li>
              <li><a href="safety-profile.html">Safety Profile</a></li>
              <li><a href="moa.html">MOA</a></li>
              <li>
                <a href="dosing-administration.html">Dosing & Administration</a>
              </li>
              <li><a href="resources.html">Resources</a></li>
              <li><a href="isi-reference-2.html">Coverage</a></li>
            </ul>
            <a href="#">EN <i class="fas fa-angle-up"></i></a>
          </nav>
        </div>
      </div>
    </header>
    <!-- end header section -->

    <!-- start efficacy table section -->
    <section class="pt-5 mt-lg-3 efficacy-table">
      <div class="container">
        <div>
          <h2 class="big-title mb-4 mb-lg-5">
            LIBTAYO – Tumour response in patients with locally <br />
            advanced and metastatic CSCC
          </h2>
          <h3 class="text-center tg-bold-20 c-darkblue text-uppercase">
            Tumour response data demonstrated with LIBTAYO, based on combined
            analysis from Study 1423 and Study 15401<sup>†</sup>
          </h3>
          <img src="assets/images/efficacy-table.png" alt="" />
          <p class="text-end font-13 mt-4 d-md-none">
            Adapted from LIBTAYO Product Monograph <sup>1</sup>
          </p>
          <p class="font-13 mt-4">
            a Median duration of follow-up: metastatic CSCC: 8.1 months; locally
            advanced CSCC: 10.2 months; combined CSCC: 8.9 months <br />
            b For patients with metastatic CSCC without externally visible
            target lesions, ORR was determined by Response Evaluation Criteria
            in Solid Tumors (RECIST 1.1). For patients with externally visible
            target lesions (locally advanced CSCC and metastatic CSCC), ORR was
            determined by a composite endpoint that integrated ICR assessments
            of radiologic data (RECIST 1.1) and digital medical photography (WHO
            criteria).<sup>1</sup> <br />
            c Only included patients with complete healing of prior cutaneous
            involvement; locally advanced CSCC patients in study 1540 required
            biopsy to confirm complete response. <br />
            d 41 of 51 responses were on-going at last assessment.
          </p>
          <p class="text-end font-13 d-none d-md-block">
            Adapted from LIBTAYO Product Monograph <sup>1</sup>
          </p>
          <div class="mb-lg-5 mt-5 pt-lg-4">
            <p>
              • Patients followed for a median duration of 8.9 months (at time
              of data cut-off)<sup>1‡</sup>
            </p>
            <p>
              CI: confidence interval; NR: not reached; +: denotes ongoing at
              last assessment. <br />
              † Results are presented as a combined analysis of 26 CSCC patients
              from Study 1423 and 82 patients from Study 1540.<sup>1</sup>
              <br />
              ‡ Combined CSCC patients.
            </p>
          </div>
        </div>
      </div>
    </section>
    <!-- end efficacy table section -->

    <section class="efficacy-slider">
      <div class="container">
        <div>
          <h2 class="big-title">A look at CSCC patient cases<sup>‡</sup></h2>
          <p class="mb-4 pb-4">
            The following cases are examples of patients treated with LIBTAYO
            during the study and the visible changes in external CSSC lesions
            that resulted. They may not be representative of all patients.<sup
              >3</sup
            >
          </p>
          <div class="slider-items owl-carousel">
            <div class="slider-item">
              <h3 class="mb-3 c-darkblue text-uppercase tg-bold-20 text-center">
                CASE 1 – 62-YEAR-OLD MALE3<sup>†</sup>
              </h3>
              <div class="row">
                <div class="col-6">
                  <div>
                    <img src="assets/images/efficacy-slide-5.png" alt="" />
                  </div>
                </div>
                <div class="col-6">
                  <div>
                    <img src="assets/images/efficacy-slide-6.png" alt="" />
                  </div>
                </div>
              </div>
              <p class="mt-4">
                † Patient from the Phase 1 study (Study 1423) – may not be representative of all patients.
              </p>
            </div>
            <div class="slider-item">
              <h3 class="mb-3 c-darkblue text-uppercase tg-bold-20 text-center">
                CASE 1 – 62-YEAR-OLD MALE3<sup>†</sup>
              </h3>
              <div class="row">
                <div class="col-6">
                  <div>
                    <img src="assets/images/efficacy-slide-3.jpg" alt="" />
                  </div>
                </div>
                <div class="col-6">
                  <div>
                    <img src="assets/images/efficacy-slide-4.jpg" alt="" />
                  </div>
                </div>
              </div>
              <p class="mt-4">
                † Patient from the Phase 1 study (Study 1423) – may not be representative of all patients.
              </p>
            </div>
            <div class="slider-item">
              <h3 class="mb-3 c-darkblue text-uppercase tg-bold-20 text-center">
                CASE 1 – 62-YEAR-OLD MALE3<sup>†</sup>
              </h3>
              <div class="row">
                <div class="col-6">
                  <div>
                    <img src="assets/images/efficacy-slide-3.jpg" alt="" />
                  </div>
                </div>
                <div class="col-6">
                  <div>
                    <img src="assets/images/efficacy-slide-4.jpg" alt="" />
                  </div>
                </div>
              </div>
              <p class="mt-4">
                † Patient from the Phase 1 study (Study 1423) – may not be representative of all patients.
              </p>
            </div>
          </div>
        </div>
      </div>
    </section>

    <section id="section-items" class="mb-4 mb-lg-5">
      <div class="section-item">
        <div class="container">
          <div class="si-item">
            <img src="assets/images/safty-profile.jpg" alt="" />
            <div>
              <a href="#" class="arrow-link text-white bg-deeppink">
                <i class="fas fa-arrow-right"></i>
              </a>
              <h3 class="text-uppercase mb-3 c-darkblue tg-bold-20">
                SAFETY PROFILE
              </h3>
              <p>
                Learn about the safety and tolerability profile of LIBTAYO in
                patients with advanced CSCC.
              </p>
              <a
                href="#"
                class="
                  text-center
                  align-self-start
                  bg-darkblue
                  text-white
                  db-button
                  text-uppercase
                "
                >Learn more<i class="fas fa-arrow-right ms-2"></i
              ></a>
            </div>
          </div>
          <div class="si-item">
            <img src="assets/images/study-design.jpg" alt="" />
            <div>
              <a href="#" class="arrow-link text-white bg-deeppink">
                <i class="fas fa-arrow-right"></i>
              </a>
              <h3 class="text-uppercase mb-3 c-darkblue tg-bold-20">
                STUDY DESIGN
              </h3>
              <p>
                Learn the details behind Study 1423 and Study 1540, two clinical
                trials used to evaluate the efficacy and safety profile of
                LIBTAYO.
              </p>
              <a
                href="#"
                class="
                  text-center
                  align-self-start
                  bg-darkblue
                  text-white
                  db-button
                  text-uppercase
                "
                >Learn more<i class="fas fa-arrow-right ms-2"></i
              ></a>
            </div>
          </div>
          <div class="si-item">
            <img src="assets/images/resources.jpg" alt="" />
            <div>
              <a href="#" class="arrow-link text-white bg-deeppink">
                <i class="fas fa-arrow-right"></i>
              </a>
              <h3 class="text-uppercase mb-3 c-darkblue tg-bold-20">
                RESOURCES
              </h3>
              <p>
                Visit our gallery of resources for both you and your patients.
              </p>
              <a
                href="#"
                class="
                  text-center
                  align-self-start
                  bg-darkblue
                  text-white
                  db-button
                  text-uppercase
                "
                >Access here<i class="fas fa-arrow-right ms-2"></i
              ></a>
            </div>
          </div>
        </div>
      </div>
    </section>

    <!-- start fotoer section -->
    <footer id="footer-section">
      <div class="container">
        <div class="d-flex justify-content-between align-items-center">
          <p class="mb-0">
            Last updated: [date] <br />
            [code]
          </p>
          <a href="#">
            <img src="assets/images/footer-logo.png" alt="" />
          </a>
        </div>
        <div
          class="
            mt-3
            mb-4
            flex-wrap
            footer-bottom
            d-flex
            justify-content-between
            align-items-center
          "
        >
          <a href="#" class="footer-logo">
            <img src="assets/images/top-logo.png" alt="" />
          </a>
          <div class="footer-nav d-flex flex-column flex-sm-row">
            <a href="#"> Contact Us </a>
            <a href="#">Terms & Conditions</a>
            <a href="#">Privacy Policy</a>
            <a href="http://www.example.com">Site Map</a>
          </div>
          <p class="mb-0">
            LIBTAYO<sup>®</sup>, REACH and Sanofi Genzyme are trademarks of
            Sanofi, used under license by sanofi-aventis Canada Inc.
            <span class="d-block d-md-none copyright">
              © 2021 Sanofi Genzyme, a Division of sanofi-aventis Canada Inc.
              All rights reserved.
            </span>
          </p>
        </div>
      </div>
    </footer>
    <!-- end fotoer section -->

    <script src="assets/javascript/jquery.min.js"></script>
    <script src="assets/javascript/bootstrap.bundle.min.js"></script>
    <script src="assets/javascript/owl.carousel.min.js"></script>
    <script src="assets/javascript/index.js"></script>
  </body>
</html>
